Orion Energy Systems, Inc. (OESX) Dividend History

Orion Energy Systems, Inc. (OESX) is a technology company that designs and manufactures energy-efficient LED lighting solutions for commercial and industrial applications. Founded in 1992 and based in Manitowoc, Wisconsin, the company focuses on providing innovative lighting products to help customers reduce energy consumption and lower operational costs through sustainable lighting systems.

2210 Woodland Drive, Manitowoc, WI, 54220
Phone: 800-660-9340
Website: https://www.orionlighting.com

Dividend History

Orion Energy Systems, Inc. currently does not pay dividends

Company News

  • Orion Energy Systems reported Q1 2026 revenue of $19.6M, with a gross margin of 30.1% and positive adjusted EBITDA of $0.2M. The company maintained its fiscal year revenue growth outlook of approximately 5% and expects to approach or achieve positive adjusted EBITDA for the full year.

    GlobeNewswire Inc.
    Featured Companies: ES
  • Orion's (OESX) fourth-quarter fiscal 2024 results reflect robust contributions from its reportable segments on the back of increased project activity, accompanied by favorable pricing actions.

    Zacks Investment Research
    Featured Companies: DY OC PHM
  • Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales. SeqLL Inc. (NASDAQ: SQL) shares surged 34.3% to $0.5377 in pre-market trading after gaining over 19% on Monday. SeqLL recently posted a wider first-quarter loss. HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 21.1% to $1.55 in pre-market trading following better-than-expected first-quarter results. Bone Biologics Corporation (NASDAQ: BBLG) shares gained 18.8% to $0.1960 in pre-market trading after gaining over 10% on Monday. Movella Holdings Inc. (NASDAQ: MVLA) rose 18.5% to $2.28 in pre-market trading after jumping around 18% on Monday. Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares rose 14.4% to $1.99 in pre-market trading. The FDA recently approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants. Navidea Biopharmaceuticals, Inc. (NASDAQ: NAVB) shares gained 14.1% to $0.1275 in pre-market trading after the company reported the sale of preferred ...

    Benzinga
    Featured Companies: BBLG CPIX HTCR MBOT MVST NCPL OMH OTLK PRSO QBTS YELP
  • OESX earnings call for the period ending March 31, 2022.

    The Motley Fool
Page data last updated 09/07/2025 06:15:27 UTC